Colombia’s Superintendence of Industry and Commerce has enacted precautionary measures against Khiron Colombia S.A.S., requested by Pharmacielo Colombia Holdings S.A.S. which has accused Khiron of unfair competition.
According to the plaintiff (Pharmacielo), legal counsel Andrés Eduardo Torres Rueda leaked sensitive information related to the structure of their commercial activity; cannabis production and manufacturing processes; expected returns; as well as data on the processing and management of the exploitation licenses, among others, to his brother Álvaro Francisco, legal representative of Khiron Colombia.
The SIC ordered the Ministry of Justice, the Ministry of Health and the National Narcotics Fund to suspend all licenses granted to Khiron for the manufacture of cannabis derivatives, as well as the use of seeds and plant cultivation. However, in order for the measures to be effective, the SIC ordered Pharmacielo to pay a bond of $500 million pesos to cover the possible damages to Khiron as a result of this cautionary decision.
Álvaro Torres, CEO of Khiron, said that they have not received any legal notices so far against the firm and that “it is strange that these actions exist since there is yet no industry or legal market for medicinal cannabis in Colombia.”
Full Content: Asuntos Legales
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI